secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0000075252-22-000055
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor Q3 GAAP EPS $0.16 vs $0.58 YoY; adjusted EBITDA margin up 140 bps
-------------------------------------------------------------------------------

- GAAP net income $12.5M ($0.16 EPS) vs $44.1M ($0.58 EPS) in Q3 2021; adjusted EPS $0.41 vs $0.74.
- Revenue $2,497M, nearly flat YoY; adjusted EBITDA $127M, margin up 140 bps.
- Patient Direct segment revenue grew 142% (11.4% pro forma for Apria); CPAP opportunities captured.
- Products & Healthcare Services segment challenged by delayed customer reorders; accelerating key initiatives.
- Generated $69M cash from operations in the quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000007525222000055/0000075252-22-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000007525222000055/omi-20221102.htm
  HTML page:      https://secwatch.observer/filing/0000075252-22-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer